In a study of cultures of fibroblast-like synoviocytes from patients with RA, the DMARDs methotrexate and sulfasalazine, have been shown to decrease the ratio of RANKL/OPG in a dose-dependent manner [40]. The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.